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Expression of Phosphacan, a chondroitin sulfate proteoglycan,
core protein in Esherichia coli as a fusion protein
with glutathione S-transferase
Sekiko ITO and Motoi OKAMOTO
Abstract
Optimal conditions for expressing a specific region of core protein of phosphacan, a chondroitin
sulfate proteoglycan known as receptor type protein tyrosine phosphatase, as fusion protein with
glutathione S-transferase (GST) in E.coli were examined. DNA fragments inserted into the
expression vector (pGEX-4T-l) were amplified by RT-PCR using mRNA purified from E18 rat brain
as template. Primers attached with BamH I or EcoR I restriction site on 5' end were used to
amplify first strand eDNA by PCR. Before ligation into the pGEX-4T-l for GST fusion protein,
PCR products were once cloned using T-A cloning system because they were not directly ligated
into the pGEX-4T-1. E.coli strain BL21 was transformed by pGEX-4T-l ligated with restriction
DNA fragment cut out from pCR II plasmid vector of T-A cloning system. The growth of
transformed BL21 was not different between the colony incubated at 3TC for 24-48 h and the colony
stored at 40C for 7-10 days after 24h incubation at 3TC. The desirable OD55o of culture medium for
inducing the expression of fusion protein by isopropylthio-,B-D-galactoside (IPTG) was from 0.6 to
1.0, because expression of native E.coli proteins per ml of culture medium was increased relatively
when IPTG was added at ODs5o more than 1.0. The expression of fusion protein reached plateau
around 6h after the induction. Relative expression of native E.coli proteins per ml of culture
medium increased thereafter. Therefore, it may be desirable to purify the fusion protein around 6h
after the induction.
Key words : phosphacan, glutathione S-transferase, BL21, IPTG, fusion protein.
INTRODUCTION
There are increasing evidence that chon-
droitin sulfate proteoglycan (CSPGs), which
constitute a family of extracellular matrix
molecules, have various biological functions in
cell proliferation, migration, differentiation,
extension of processes
'
-
8). They also play
important roles in survival or death of neuronal
cells, viral infection, and degenerative disorders
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of central nervous system9 - I3). CSPGs are
structurally complex molecules having polysac-
charide side chains attached to core proteins.
Glycosaminoglycan side chains are indispens-
able for some biological functions7,I4-IS), while
core proteins play the leading role in other
biological functions 2,S,I6). In conventional bio-
chemical strategies, core proteins or
glycosaminoglycans separated by enzymatic
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digestion of CSPGs with glycosidases or
proteinase for discriminating functions of core
proteins from those of glycosamirioglycans.
In previous studies, we reported that soluble
CSPGs purified from neonatal rat brain protect-
ed both acute and delayed cell death induced by
glutamate of primary cultured cortical and
hippocampal neurons of the rat, and that the
protective action depended on core proteins
rather than glycosaminoglycans9- 10). We found
that a specific domain of the core protein of
phosphacan17 - 1B), a brain soluble CSPGs, might
have the leading role in protective action
against delayed neuronal death induced by
glutamate in experiments using fragments of
core proteins purified by chondroitinase diges-
tion and CNBr treatment (unpublished data).
However, we could not rule out the role of
polysaccharides, because phosphacan have ker-
atan sulfate side chains and oligosaccharides
beside the chondroitin sulfate side chains, and
keratan sulfates and oligosaccharides are not
removed from core protein after chondroitinase
digestion. In this context, we planed to purify
recombinant phosphacan core protein after
expressing it as a fusion protein with glutath-
ione S-transferase (GST) in Esherichia coli.
In this study, we examined the optimal condi-
tions for ligation of DNA fragments into plas-
mid vector, transformation of E.coli, and
expression of the fusion protein with GST.
Primers for PCR were designed to amplify
DNA correspond to the domain of phosphacan
core protein which was identified to have pro-
tective action against delayed neuronal death
induced by glutamate in our other experiments.
MATERIALS and METHODS
1. EXTRACTION OF mRNA FROM THE
RAT BRAIN
mRNA was extracted from the brain of 18-
day-old rat fetuses (Spr-ague-Dawley rat, Kurea,
Osaka, Japan), using the Fast Track mRNA
Isolation Kit (Invitrogen, USA). Brains were
placed in Fast Track-lysis buffer, homogenized
with a machine-driven Teflon pestle homogen-
izer for 15-30 seconds, and incubated at 45°C for
60 min. The NaCI concentration of the lysate
was adjusted to 0.5M by adding 5M NaCI stock
solution. Oligo (dT) (Invitrogen, USA) Cellu-
lose were added to the lysate, incubated at
room temperature for 60min, and spined at
room temperature for 5min at 3200rpm. Fol-
lowing centrifugation, the Oligo (dT) Cellulose
were washed three times with low salt wash
buffer. Oligo (dT) Cellulose were suspended in
low salt wash buffer, pipetted onto a spin-
column, and spined at room temperature for
10sec at 5000rpm. The column was washed
repeatedly with low salt wash buffer until the
OD26o of the "flow-through" was :::;; 0.05. Elu-
tion buffer was added to the column, and spined
for 10sec to collect the elution containing
mRNA. mRNA were precipitated with 0.15
volume of 2M Sodium Acetate and 2.5 volume
of 100% ethanol, and spined for 15min at
15000rpm. Following centrifugation and drying
by vacuum, the mRNA pellet was resuspended
in 10mM Tris-HCI (pH7.5).
2. REVERSE TRANSCRIPTION/PCR
Using the First-Strand cDNA Synthesis Kit
(Pharmacia Biotech) and the PCR Master Kit
(Boehringer Mannheim), 1.0.ug of mRNA was
reverse-transcribed for 60min at 3TC in a vol-
ume of 15.u1. Oligo d(T)12-18 (Takara, KYOTO,
Japan) was used as the primer for reverse tran-
scription. Following incubation, All sens and
antisense primers, and PCR components except
the Taq polymerase were added and heated for
2min at 95"C. Primers used in PCR, combina-
tion of primers, and the size of PCR products
are shown in Fig. 1. After addition of Taq
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OKA-1S (sense)
343 349
5 '-GGATCCATTGAGAAGTTTGCGGTTCTG-3'
OKA-2AS (ant i sense)
445 439
5 '-GAATTCACCGGGATTCAAGCCAGTGTC-3'
OKA-2S (sense)
407 413
5 ~GGATCCGACATGCCTACTGAGGATGCT-3'
OKA-l AS (ant i sense)
417 410
5 ~GAATTCGAGGTCAAGTTCAGCATCCTC-3'
20mg/dl of 5-Bromo-4-chloro-3-indolyl-p-D-
galactopyranoside (X-gal) (WAKO, OSAKA,
JAPAN) and 100mM of isopropylthio-P-D-
galactoside (IPTG) (AMBION). The LB plates
were incubated at 3TC for 24hr. Plasmid DNA
were purified from One Shot cells (INVa F) by
using boiling methods. At least 20 single white
colonies were transferred into 2ml of X 2 YTA
medium (Tryptone 16g, Yeast extract 109 and
ampicillin 100mg/l), and incubated overnight at
37 with vigorous agitation. The culture
medium was spined at 3000rpm for 10min at
4°C. Following centrifugation, the bacterial
pellet was resuspended in 350j.l1 of STET (8%
sucrose, 0.5% Triton-XIOO, 50mM EDTA,
10mM Tris-HCI (pH8.0)). A prepared solution
of lysozyme (50mg/ml) (Boehringer Mannheim)
was added to the lysate, and placed in a boiling-
water bath for lmin. The bacterial lysate was
spined at 12000rpm for 15min. After centrifuga-
tion, the pellet of bacterial debris were removed
from the microfuge tube with a sterile tooth-
pick. The isopropanol and 3M sodium acetate
was added into the supernatant, mixed by vor-
tex, and placed the tube for 15min at -20°C.
After precipitation for 15min, microfuge tube
was spined at 4°C for 15min at 12000rpm. The
pellet was rinsed with 70% ethanol, and evapor-
ated in desiccator. The plasmid DNA was
redissolved in 50j.l1 of RNase (200j.lg/ml), in-
cubated at room temperature for lhr. A pre-
pared solution of 20% Polyethylene Glycol 6000
was added to the lysate, placed at 4°C for lhr,
and spined at 12000rpm for 5min. After
centrifugation, the pellet was rinsed with 70%
ethanol, and evaporated in desiccator. Plasmid
DNA sequencing was performed by using
PRISM Ready Reaction DyeDeoxy Terminator
Cycle Sequencing Kit (Applied Biosystems).
The plasmid DNA was amplified with ampli
taq DNA polymerase and universal primers for
225bp
120bp
312bp
Pl :OKA-1S - OKA-1AS
P2:0KA-2S - OKA-2AS
P3:0KA-1S - OKA-2AS
polymerase, the template was placed in an
heating/cooling block (Zymoreactor AB-1800,
ATTO, Japan). The reaction was started by
heat denaturation of the template (2min, 94°C).
The template was amplified by 30 PCR cycles
(94°C (lmin), 55°C (lmin), and 72°C (2min)) foll-
owed by a 7-min extension at 72°C after the
final cycle. After purification by phenol/chlo-
roform extraction followed by precipitation
with ethanol, the PCR products were analyzed
by agarose (3%-Nu Sieve 3: I agarose, FMC,
USA)-ethidium bromide (0.5mg/dl) gel electro-
phoresis.
3. SUBCLONING OF THE PCR PRODUCTS
AND DNA SEQUENCING
Using the T-A Cloning Kit (Invitrogen), 500ng
of PCR products were ligated into 25ng of pCR
II vector with 3'T-overhangs19l• The reaction
medium was incubated at 16°C for overnight,
transformed into One Shot cells (INVa F) by
heat shock, and spreaded on labeled LB agar
plates containing 100j.lg/ml of ampicillin,
Fig. 1. Sequences of synthetic oligonucleotide primer
for PCR. These primers for PCR were designed
to amplify DNA correspond to the domain of
phosphacan core protein which identified to
have protective action against delayed neuronal
death induced by glutamate. Primers are
attached the recognition sequence for a restric-
tion enzyme (BamH I, EcoR I) at 5' terminus.
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the sequencing of bacteriophage M13 recom-
binant clones (universal M13 forward (- 20)
primer and universal M13 reverse primer).
Amplification was performed using 25 cycles of
96·C (lmin), 50·C (0.5min), 60·C (4min). After
amplification, the PCR products were extracted
by phenol/chloroform, and precipitated with
ethanol. The purified plasmid DNA was
suspended in sample loading buffer. The sam-
ples were loading onto polyacrylamide gel
containing 5.25% long ranger (FMC
Bioproducts-Europe) and 8.3M urea for 16hr.
Beside the DNA sequencing (373 DNA
sequence system, Applied Biosystems) pCR II
plasmid was purified from INVer F, digested
with BamH I and EcoR I, and separated by
agarose gel electrophoresis to purify sticky-end
PCR product. The resulting fragments were
subcloned into pGEX (4T-1) by using E.coli
strain BL21.
4. EXAMINATION OF OPTIMAL CONDI-
TION FOR EXPRESSION OF THE
FUSION PROTEIN
Purified PCR product was ligated into pGEX-
4T-1 plasmid vector at 3TC for 30min or 16·C
overnight by using Ligation Kit (Takara,
KYOTO, JAPAN), and introduced by a heat
shock of 42"C for 90sec to transform E.coli
BL21. A single colony of E coli transformed
with the pGEX (4T-1) recombinant were trans-
ferred into 2ml of X 2 YTA medium in test
tubes, and incubated at 30·C or 3TC with vigor-
ous agitation until the ODsso reached from 0.6 to
2.0. 100mM of IPTG was added to the bacterial
medium at a final concentration of O.lmM, and
then the bacterial lysate was continued incuba-
225bp~
M P 1 P2 P3
~312bp
Fig. 2. Ethidium bromide-agarose gel electrophoresis of the PCR products. mRNA was extracted from the brain of
l8-day-old rat fetuses. Oligo d(T)I2-,8 was used as the primer for reverse transcription. The templates were
amplified with Taq polymerase and synthesized primers with restriction enzyme recognition site, using 30
temperature·step cycles of 94'C (lmin), 55'C (lmin) and 72'C (2min) with a 2min denaturation at 94'C before
the cycles and a 7min extension at 72'C after the final cycle. The reaction products were electrophoresed on
3% agarose (NuSieve 3: 1) gel and stained with ethidium bromide.
M; DNA biomarker low (Bioventures, INC): 1.0,0.7,0.52,0.5,0.4,0.3,0.2,0.1 and 0.05kb respectively. 1; OKA
lS-OKA lAS: 225bp. 2; OKA 2S-0KA 2AS: 120bp. 3; OKA IS-OKA 2AS: 3l2bp.
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tion at 30·C or 3TC for another 24hr. During
induction, 1.5ml aliquots of induced culture
were sampled at 1, 2, 4, 6, 12, 18 and 24hours
after the addition of IPTG. These samples
were immediately spined at 10000rpm for 1min
at room temperature. Each pellet was
resuspended in 100,u1 of SDS gel-loading buffer,
heated to lOOT for 5min and spined at
15000rpm for 1min at room temperature. Ten
,ul of each supernatant was loaded on SDS-
polyacrylamide gel of 15% concentration. The
gel was stained with Coomassie Brilliant Blue.
RESULTS
1. REVERSE TRANSCRIPTION/PCR
The PCR products from rat's brain mRNA
were shown in Fig. 2. All three PCR products
were electrophoresed at expected base-pair size
of 225bp (PI), 120bp (P2) and 312bp (P3) respec-
tively on agarose gel. At first, we used primers
without restriction enzyme-recognition site for
RT/PCR. The PCR products was digested with
Klenow fragment, phosphorylated, and then a
bluntended fragment of PCR products was
ligated into pGEX (4T-2), but not successfully
ligated into the vector. Therefore, we used
primers having 5'restriction enzyme-
recognition site to produced double-strand
DNA having BamH I and EcoR I site at each
end.
2. LIGATION AND TRANSFORMATION
The PCR products were not successfully
ligated into pGEX plasmid (4T-1) even when
they were digested with BamH I and EcoR I to
have asymmetric sticky-end on each side. Then
we used a T-A cloning kit, in which the PCR
products with 3'A-overhangs could be ligated
into pCR II vector with 3'T-overhangs. The
..... p
..... Pl
Fig. 3. Ethidium bromide·agarose gel electrophoresis of 225bp BamH I-EcoR I restriction fragment. Plasmid D A
was purified from One Shot cells (I VaF) by using boiling methods as described in materials and methods.
Purified plasmid DNA was digested with BamH I and EcoR I, and separated by agarose gel electrophoresis.
M; D A biomarker low: 1.0,0.7, 0.52, 0.5, 0.4, 0.3, 0.2, 0.1 and 0.05kb. The fragments of 225bp (indicated by
the arrow) were cut out from the gel, and purified as described in materials and methods to ligate into
pGEX-4T-1.
- 67-
Sekiko Ito et al.
PCR products were successfully ligated into
pCR II by T-A cloning kit. We could confirm
that PCR product PI and P2 had correct nu-
cleotide sequence but nucleotide sequence of P3
was incorrect by DNA sequencing. Then we
used PCR product PI to examine the optimal
conditions for expression of fusion protein with
GST. The pGEX (4T-1) ligated a 225bp BamH
I-EcoR I restriction fragment (Fig. 3) was pur-
ified from One shot cell (INVa F). At first, we
used E.coli strain JM109 for transformation,
but this E.coli strain JM109 express little fusion
protein. Then we changed the strain of E.coli
to BL21, E.coli strain BL21 expressed the
fusion protein.
3. OPTIMAL CONDITION FOR EXPRES-
SION OF FUSION PROTEIN
The colonies of BL21 were picked up from
two different LB plate containing ampicillin.
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Fig. 4. Growth curve of transformed E.coli BL21 at
30°C. The colonies of BL21 were picked up from
two different LB plate containing ampicillin
and incubated at 30"C with vigorous agitation.
The one was incubated at 3TC for 24 to 48hrs
after the plating of E.coli. Another was stored
at 4°C for 7 to 10 days after the incubation at
3TC for 24hrs. During incubation, ODsso of
culture medium was measured at every 30 or
60min.
Closed circles: colonies incubated at 37°C for 24
to 48hrs. Closed triangles: colonies stored at
4°C for to 10 days after the incubation at 3TC
for 24hrs.
The one was incubated at 3TC for 24 to 48hrs
after the plating of E.coli. Another was stored
at 4"C for 7 to 10 days after the incubation at
3TC for 24hrs. The growth curve of two col-
onies were very similar to each other (Fig. 4).
We examined the effect of temperature on
growth curve of transformed E.coli in the next
experiment. As expected, E.coli grew rapidly
at 3TC compared to growth temperature at 30"
C. However, majority of GST fusion protein
was held in insoluble fraction when E.coli was
grown at 3TC. Therefore, transformed BL21
was incubated in a shaking water bath at 3TC
in the next two experiments.
To examine the adequate ODsso to induces
the expression of GST fusion protein, IPTG
was added to the medium at ODsso from 0.6 to
1.6. Following the another 13-18hrs incubation
at 30"C, the expression of fusion protein was
analyzed by SDS-PAGE (Fig. 5). ODsso at the
induction with IPTG did not have so much
effect on the expression of fusion protein, but
production of native proteins of E.coli was
slightly increased when IPTG was added at
ODsso more than 1.0. There was no difference
between colonies incubated at 3TC and colonies
stored at 4"C.
Finally, duration of incubation for the expres-
sion of fusion protein was examined. A colony
was picked up from LB plate incubated at 3TC
for 48hrs, and incubated in 20ml of 2x YTA
medium at 30"C. IPTG was added to the
medium at ODsso =0.6. One ml of the medium
was sampled at 1, 2, 4, 6, 12, 18 and 24hours
after the induction. Each sample was
centrifuged at 10000rpm for lOsee, and pellet
was stored at - 20"C until the analysis. The
expression of fusion protein was analyzed by
SDS-PAGE. The expression of fusion protein
reached the maximum level around 6h after the
IPTG induction, and relative concentration of
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Fig. 5. Relation between the OD"o at the time of IPTG induction and the expression of fusion protein. The colonies
of BL21 were picked up from two different LB plate as described in results and Fig. 4 and incubated in 2 X
YTA medium at 3TC with vigorous agitation until the ODsso reached from 0.6 to 1.4. When the ODsso reached
from 0.6 to 1.4, IPTG was added to the bacterial medium at a final concentration of O.lmM. One ml of
medium was sampled at 13-18h after the IPTG induction, and the pellet of bacteria was boiled for 5min in
SDS sample buffer. Ten pI of the aliquot was electrophoresed on SDS-polyacrylamide gel (4.5% stacking,
15% separating) to examine the expression of fusion protein. The numbers on the top of gel indicate ODsso
when IPTG was added to the bacterial medium.
M 1 2 4 6 12 1 8 24
Fig. 6. Relation between the time after the addition of IPTG and the expression of fusion protein. A colony of BL21
was picked up from LB plate incubated at 3TC for 24 to 48hrs. The colony was incubated at 30°C until the
ODsso reached 0.6, and then IPTG was added to the bacterial medium at a final concentration of O.lmM. One
ml aliquot of culture medium was sampled at I, 2, 4, 6, 12, 18 and 24hours, after the addition of IPTG. The
pellet was boiled for 5min in SDS sample buffer, and the aliquot of lOp I was electrophoresed on SOS-
polyacrylamide gel (4.5% stacking, 15% separating). The expression of fusion protein (indicate by the arrow)
reached the peak at 12h after the addition of IPTG.
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native E.coli proteins was increased thereafter
(Fig. 6).
DISCUSSION
The PCR products were not directly ligated
into pGEX plasmid vector regardless of the
constitution of their ends; blunt or sticky, or of
the protocol of ligation reaction; ligated at 3TC
for 30min or at 16'C overnight. However, they
were successfully ligated into the expression
vector after cloned once by T-A cloning system.
The results indicate that the biochemical' or
biophysical properties of DNA fragments cut
out from pCR II vector is different from those
of PCR products, or the conditions we used in
direct ligation of PCR products into pGEX
vector were inadequate. The lattered was
supported by the fact that PCR products having
sticky ends were directly ligated by using
another ligation kit (data not shown), although
we are confirming that transformed E.coli have
pGEX plasmid vector properly ligated with
PCR products in our ongoing experiments. The
ratio between insert DNA and plasmid is a
important factor for ligation, and may be a
reason of our failure in ligating directly into
plasmid vector. But this is not probable
because we examined all ratios from 10 : 1 to 1 :
1.
The expression of fusion protein was slow
when E.coli jMI09 was used as the host of
expression vector. That is to say, it required
longer time in jMI09 than in BL21 to reach the
peak of expression of the fusion protein.
Although we did not fully examined the optimal
conditions for the expression of fusion protein
in jMI09, this imply that the strain of host
bacteria influence the expression of protein
concerned, and that jMI09 is not suitable for
the expression of GST fusion protein or core
protein of phosphacan.
Growth of transformed E.coli BL21 was same
between the fresh colonies incubated 24-48h at
3TC and the colonies stored at 4'C for 7-10days
after the incubation at 3TC (Fig. 4). This was
the case when transformed BL21 was incubated
at 3TC (data not shown). There were no differ-
ences in the expression of fusion protein
between the two colonies (Fig. 5). The results
indicate that colony of transformed E.coli can
be stored at 4'C for at least 7-10 days on LB
plate.
ODsso at the time of IPTG induction did not
have distinct influence on the expression of
fusion protein itself when IPTG was added to
culture medium at ODsso 0.6-1.4. However,
expression of native protein of the host BL21,
which may influence the efficiency of purifica-
tion of GST fusion protein, was increased when
IPTG was added at ODsso over 1.0. Therefore,
it may be desirable to induce the expression of
fusion protein at ODsso .
The expression of fusion protein was consid-
ered to reach the maximum level around 6h
after the induction with IPTG although we did
not calculate the relative amount of expressed
protein in the same mass of E.coli. The amount
of fusion protein in per ml of culture medium
was increased almost in parallel with the
increase of ODsso thereafter. But expression of
native E.coli protein in per ml culture medium
was also increased when the culture was
continued for more than 12h. It is desirable to
exclude contamination of native E.coli protein
for purifying fusion protein, because unknown
proteins may affect the recovery of fusion
protein. Therefore it may desirable to purify
fusion protein around 6h after the induction.
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大腸菌を用いたフォスファカン (コンドロイチン硫酸プロテオグリカン)
の融合コア蛋白の発現条件の検討
伊藤音子 岡本 基
要 約
コンドロイチン硫酸プロテオグリカンの一種であるフォスファカンのコア蛋白の特異領域を,グルタ
を行った.胎生18日目のラット脳から抽出したmRNAを歯型として,RT-PCRによって増幅したDNA
フラグメントを発現ベクターに挿入した｡PCRの為のプライマーは,BamH IとEcoR Iの酵素消化
部位を5'末端に組み込んだものを用いた｡GST融合蛋白を作製するために,PCR産物を一旦,T-Aク
ローニングシステムに組込み,その後プラスミド精製と制限酵素消化によって目的のフラグメントを切
り出した後,pGEXベクターに再度組み込ませ,大腸菌 (BL21)を形質転換した｡形質転換した大腸菌
(BL21)について,24-48時間培養後に,37oCで保有したものと,37oCで24時間培養後に4oCで7-10
日間保有したものとの増殖曲線を比較したところ,両者に有意な差は認められなかった｡融合蛋白の誘
導に必要なイソプロピルチオ βー-D-ガラクトシド(IPTG)の添加の時期は,菌培養液の吸光度(550nm)
が1.0以上の場合には融合蛋白に比べて他の大腸菌固有の蛋白の割合が相対的に増大してしまう為,ま
た,吸光度が0.6以下では菌量が少ない為,吸光度が0.6-1.0を示す時期に添加する方がより望ましいこ
とがわかった｡IPTGによる誘導後,融合蛋白の発現は6時間でプラトー に達し,その後は大腸菌固有の
内在蛋白量の割合が相対的に増加した｡以上の結果より,融合蛋白の発現を誘導するための至適条件は,
次のように決定された｡1.IPTG誘導は,培養液の吸光度 (550nm)が0.6-1.0の際に開始する｡2.
IPTGによる誘導時間は,6時間とする｡
キーワード:フォスフアカン,グルタチオン Sー-トランスフェラーゼ,BL21,IPTG,融合蛋白
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